SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001601830-24-000044
Filing Date
2024-04-25
Accepted
2024-04-25 17:08:02
Documents
2
Period of Report
2024-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1714079272.html 3  
1 FORM 3 wk-form3_1714079272.xml 3 1585
2 EX-24 powerofattorney-najatkhan.htm EX-24 4334
  Complete submission text file 0001601830-24-000044.txt   7462
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Khan Najat (Reporting) CIK: 0002020969 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 24877389